Medrx: Announcement of revised financial estimates.
Medrx: Announcements of individual stocks: Notification of completion report received for MRX-5LBT review.
Medrx: Change report.
Medrx: Change report.
Medrx: Announcement of the massive exercise of the 29th subscription rights (with an exercise price adjustment clause) issued by third-party allotment.
Medrx: Announcements of individual stocks regarding the monthly exercise status of the 29th subscription rights (with exercise price adjustment clause) issued through a third-party allocation.
Medrx: Announcements of individual stocks: Notice of the start of the Alto-101 Phase II clinical trial.
Medrx: Correction Report (Mass Ownership Report/Change Report)
Medrx: Change Report
Medrx: Announcement regarding the determination of the issuance content of the subscription rights (stock options) for solicitation.
Medrx: Notice regarding the monthly exercise status of the 29th Stock Acquisition Rights (with exercise price amendment clause) issued by third party allotment
MEDRX: Change Report
MEDRX: Change Report
MEDRX: Extraordinary Report
MEDRX: Notice Concerning Issuance of Stock Acquisition Rights (Stock Acquisition Rights with Performance-Linked Conditions and Market Capitalization Conditions) and Stock Acquisition Rights (Stock Options)
MEDRX: Change Report
MEDRX: Notice regarding mass exercise, completion of exercise, and monthly exercise status of the 28th Stock Acquisition Rights (with exercise price amendment clause) issued by third party allotment
MEDRX: Change Report
MEDRX: Notice Concerning Mass Exercise of the 28th Stock Acquisition Rights (with Exercise Price Amendment Clauses) Issued by Third-Party Allotment
MEDRX: Confirmation letter
No Data